IP Library Assignment 030322/0288
Patent Assignment
Reel/Frame 030322/0288

Change of Name

Recorded: 2013-04-30 Pages: 2
Assignor
EURAND, INCORPORATED
Executed: 2011-07-12
Assignee
APTALIS PHARMATECH, INC.
845 CENTER DRIVE, VANDALIA, OHIO, 45377
Covered Property (1)
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 8,840,925 →
Application: 13/455,942 →
Publication: US 2013/0108703
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 30, 2013
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 030317/0340 →
Patent Security Agreement Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name Aug 5, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036283/0261 →
U.S. Patent Security Agreement Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276 Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →